EGFR and cancer: However, the combination of any EGFR TKI with an anti-CD47 antibody dramatically eliminated cancer cells and prevented development of persister cells (Figure 3, A–C; Supplemental Figure 7; Supplemental Figure 8, A and B; and Supplemental Video 4).